Company description:

OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Job description:

Join Us in Changing Lives

AtOXB, our people are at the heart of everything we do. Were on a mission to enable life-changing therapies to reach patients around the worldand were looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.

Were currently recruiting for a Sample Management Coordinator to join our Quality ControlTeam. In this role, you will receive, store, issue, pack, ship, organise and dispose of samples in a controlled manner, playing a key part in advancing our mission and making a real difference.

Your responsibilities in this role would be:

• Receiving samples from manufacturing sites, checkingcondition, ensuring samples are logged inand stored appropriately

• Organising and preparing outgoing shipments of samples to external testing organisations / clients

• Navigating LIMS processes for sample management activities

• Ensuring any discrepancies are noted and dealt within a timely manner

• Ensuring a good standard of record keeping and documentation

• Authoring and reviewing of Standard Operating Procedures (SOPs) and other documentation

• Ownership and troubleshooting of processes to ensure procedural efficiencies

• Responsible for liaising and leading meetings with other teams / departments

We are looking for:

• Educated to a minimum of?GCSE or equivalent qualification level orable todemonstraterequired skillsgained withinanotherworkplace

• Experience using LIMS (not essential)

• A genuine interest and drive to work in science

• Good interpersonal and communication skills (written and verbal)

• Highly organised and motivated with excellent attention to detail

• Knowledge and experience of MS Office, Word, Excel & Outlook

About Us:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than30years of experience in viral vectors; the driving force behindthe majority ofgene therapies.

OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturingexpertisein lentivirus, adeno-associated virus (AAV)and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatoryexpertise.

Why Join Us?

• ??Competitive total reward packages
• ??Wellbeing programmesthat support your mental and physical health
• ??Career development opportunitiesto help you grow and thrive
• ??Supportive, inclusive, and collaborative culture
• ??State-of-the-art labs and manufacturing facilities
• ?? A company that lives its values:Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

Profile description:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than30years of experience in viral vectors; the driving force behindthe majority ofgene therapies.

OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturingexpertisein lentivirus, adeno-associated virus (AAV)and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatoryexpertise.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. xbpsjku These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.